Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-21-000122
Filing Date
2021-06-21
Accepted
2021-06-21 16:38:31
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162430788386168.html 4  
1 FORM 4 wf-form4_162430788386168.xml 4 6494
2 POWEROFATTORNEY_AHOOPER powerofattorney_ahooper.htm EX-24 7575
  Complete submission text file 0001651308-21-000122.txt   15517
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
HOOPER ANTHONY C (Reporting) CIK: 0001277244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 211031247

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations